Sebia
Norcross
About Sebia
Sebia is the provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Funding stage: M&A
- Last round: Private Equity (Aug 2017)
- Website: sebia.com
- Phone: 33 1 69 89 80 80
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/sebia-2243171 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.